Faculty of Medicine

By Shawn Hayward, Montreal Neurological Institute and Hospital

Discovery will aid development of treatments for this debilitating disease

Scientists at the Montreal Neurological Institute and Hospital (MNI) have identified novel gene mutations that cause hereditary spastic paraplegia (HSP), a step forward in efforts to treat this debilitating disease.

Classified as: Guy Rouleau, MNI, Montreal Neurological Institute and Hospital, HSP, hereditary spastic paraplegia, gene mutation, debilitating disease, weakness, spasticity, CanHSP, Canadian Institutes for Health Research
Published on: 10 May 2016

McGill Newsroom

Discovery offers hope for more effective treatments of deadly glioblastomas

A gene known as OSMR plays a key role in driving the growth of glioblastoma tumors, according to a new study led by a McGill University researcher and published in the journal Nature Neuroscience.

Classified as: neuroscience, brain, Lady Davis Institute, science and technology, tumor, glioblastoma, tumour, Jahani-Asl, OSMR, neuroproject
Published on: 25 Apr 2016

McGill Newsroom

CREATE project to prepare graduates for high-skills work in surgical-devices industry

A team led by McGill University professor Jake Barralet will receive $1.65 million from the Natural Sciences and Engineering Research Council of Canada to provide nearly 90 students with cross-disciplinary training to prepare them for high-skill jobs in the surgical devices industry.

Classified as: Natural Sciences and Engineering Research Council of Canada, NSERC, Collaborative Research and Training Experience, science and technology, surgical-devices industry, Jake Barralet, Greg Fergus, Science and Economic Development, Rosie Goldstein
Published on: 14 Apr 2016

By Fergus Grieve, McGill Newsroom

Depression, metabolic factors combine to boost risk of developing diabetes, study finds 

Depression may compound the risk of developing type 2 diabetes in people with early warning signs of metabolic disease, according to researchers from McGill University, l'Université de Montréal, the Institut de recherches cliniques de Montréal and the University of Calgary.

Classified as: health, depression, diabetes, Norbert Schmitz, metabolic disease, Institut de recherches cliniques de Montréal, type 2, Molecular Psychiatry, neuroproject
Published on: 12 Apr 2016

By Tod Hoffman, Lady Davis Institute 

Research reveals that even a tiny mutation can allow the HIV virus to become resistant to therapies using the CRISPR/Cas9 gene-editing platform

Classified as: Research, DNA, faculty of medicine, HIV, McGill News, CRISPR, gene-editing, Cell Reports, résistance, antiviral, Chen Liang
Published on: 8 Apr 2016

McGill University Health Centre

RI-MUHC will lead an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based development disabilities

RI-MUHC will lead an innovative pan-Canadian network that aims to improve life outcomes for children with brain-based development disabilities

Classified as: children, disabilities, McGill University Health Centre, health and lifestyle, Annette Majnemer, brain-based development disabilities, SPOR, Jane Philpott, Steven Miller, Dan Goldowitz
Published on: 31 Mar 2016

McGill Newsroom

McGill, UCLA study of low- and middle-income countries shows paid maternity leave policies could help prevent infant deaths

For each additional month of paid maternity leave offered in low- and middle-income countries (LMICs), infant mortality is reduced by 13%, according to a new study by researchers from McGill University and UCLA Fielding School of Public Health.

Classified as: Biostatistics, Jody Heymann, Department of Epidemiology, health and lifestyle, maternity, UCLA Fielding School of Public Health, PLoS Medicine, child death, maternal death, and Occupational Health, McGill’s Institute for Health and Social Policy, Arijit Nandi
Published on: 30 Mar 2016

McGill Newsroom

Canadian drug safety network provides reassuring evidence regarding risk of heart failure of anti-diabetes medications

Incretin-based drugs, a type of medication used to treat type 2 diabetes, do not increase the risk of being hospitalized for heart failure relative to commonly used combinations of oral anti-diabetic drugs, according to a new study published in the New England Journal of Medicine.

Classified as: drugs, jewish general hospital, diabetes, Lady Davis Institute (LDI), Canadian Institutes of Health Research (CIHR), health and lifestyle, New England Journal of Medicine, Heart failure, incretin, Canadian Network for Observational Drug Effect Studies, Drug Safety and Effectiveness Network
Published on: 24 Mar 2016

By Maya-Olivia Eyssen, Montreal Neurological Institute and Hospital

Montreal high school students to take part in brain quiz.

Classified as: Brain Bee, Montreal Neurological Institute and Hospital, contest, synapses, axons, cerebral, Canadian National Brain Bee, Neuroscience: Science of the Brain
Published on: 9 Mar 2016

By Julie Robert, McGill University Health Centre

Hip fractures are one of the most common injuries sustained by the elderly population following a fall.

Classified as: Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, health and lifestyle
Published on: 4 Mar 2016

Pages